Curaleaf Holdings (CURLF) Operating Expenses (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Operating Expenses of $156.5 million in Q1 2026, down 99.9% quarter-over-quarter from $158.9 billion in Q4 2025, and up 7.07% on a YoY basis from $146.2 million in Q1 2025.
Curaleaf Holdings (CURLF) Operating Expenses (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Operating Expenses history runs 8 years deep, the most recent figure standing at $156.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 7.07% year-over-year to $156.5 million; the TTM figure through Mar 2026 stood at $308.5 billion (up 50134.88% YoY), while the FY2025 annual figure was $605.6 million, down 1.7% from the prior year.
- Operating Expenses was $156.5 million for Q1 2026 at Curaleaf Holdings, down from $158.9 billion in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $158.9 billion in Q4 2025 to a low of $134.8 million in Q3 2023.
- Historically, Operating Expenses has averaged $30.1 billion across 5 years, with a median of $152.9 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses sank 99.88% in 2024, then surged 97513.1% in 2025.
- A 5-year view of Operating Expenses shows it stood at $159.6 million in 2022, then soared by 88994.43% to $142.2 billion in 2023, then tumbled by 99.88% to $163.6 million in 2024, then soared by 96997.67% to $158.9 billion in 2025, then sank by 99.9% to $156.5 million in 2026.
- The last three Operating Expenses figures came in at $156.5 million (Q1 2026), $158.9 billion (Q4 2025), and $155.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 96.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 475.11 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | 156.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.54 Mn |
| Dec 31, 2025 | 158.88 Bn |
| Sep 30, 2025 | 155.71 Mn |
| Jun 30, 2025 | 149.27 Bn |
| Mar 31, 2025 | 146.20 Mn |
| Dec 31, 2024 | 163.63 Mn |
| Sep 30, 2024 | 151.29 Mn |
| Jun 30, 2024 | 152.92 Mn |
| Mar 31, 2024 | 148.20 Mn |
| Dec 31, 2023 | 142.23 Bn |
| Sep 30, 2023 | 134.84 Mn |
| Jun 30, 2023 | 152.04 Mn |
| Dec 31, 2022 | 159.63 Mn |
| Sep 30, 2022 | 135.18 Mn |
| Jun 30, 2022 | 143.90 Mn |
| Dec 31, 2021 | 136.24 Mn |
| Sep 30, 2021 | 140.35 Mn |
| Jun 30, 2021 | 130.22 Mn |
| Mar 31, 2021 | 104.72 Mn |
| Dec 31, 2020 | 102.45 Mn |